Cargando…
Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness
BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226581/ https://www.ncbi.nlm.nih.gov/pubmed/22078942 http://dx.doi.org/10.1186/1746-6148-7-70 |
_version_ | 1782217645916946432 |
---|---|
author | Atkins, Katherine E Read, Andrew F Savill, Nicholas J Renz, Katrin G Walkden-Brown, Stephen W Woolhouse, Mark EJ |
author_facet | Atkins, Katherine E Read, Andrew F Savill, Nicholas J Renz, Katrin G Walkden-Brown, Stephen W Woolhouse, Mark EJ |
author_sort | Atkins, Katherine E |
collection | PubMed |
description | BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the epidemiological consequences of putative control strategies, it is imperative to understand how virulence is defined and how this correlates with host mortality and infectiousness during MDV infection. We present a mathematical approach to quantify key epidemiological parameters. Host lifespan, virus latent periods and host viral shedding rates were estimated for unvaccinated and vaccinated birds, infected with one of three MDV strains. The strains had previously been pathotyped to assign virulence scores according to pathogenicity of strains in hosts. RESULTS: Our analyses show that strains of higher virulence have a higher viral shedding rate, and more rapidly kill hosts. Vaccination enhances host life expectancy but does not significantly reduce the shedding rate of the virus. While the primary latent period of the virus does not vary with challenge strain nor vaccine treatment of host, the time until the maximum viral shedding rate is increased with vaccination. CONCLUSIONS: Our approach provides the tools necessary for a formal analysis of the evolution of virulence in MDV, and potentially simpler and cheaper approaches to comparing the virulence of MDV strains. |
format | Online Article Text |
id | pubmed-3226581 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32265812011-11-30 Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness Atkins, Katherine E Read, Andrew F Savill, Nicholas J Renz, Katrin G Walkden-Brown, Stephen W Woolhouse, Mark EJ BMC Vet Res Research Article BACKGROUND: Marek's disease virus (MDV) is an economically important oncogenic herpesvirus of poultry. Since the 1960s, increasingly virulent strains have caused continued poultry industry production losses worldwide. To understand the mechanisms of this virulence evolution and to evaluate the epidemiological consequences of putative control strategies, it is imperative to understand how virulence is defined and how this correlates with host mortality and infectiousness during MDV infection. We present a mathematical approach to quantify key epidemiological parameters. Host lifespan, virus latent periods and host viral shedding rates were estimated for unvaccinated and vaccinated birds, infected with one of three MDV strains. The strains had previously been pathotyped to assign virulence scores according to pathogenicity of strains in hosts. RESULTS: Our analyses show that strains of higher virulence have a higher viral shedding rate, and more rapidly kill hosts. Vaccination enhances host life expectancy but does not significantly reduce the shedding rate of the virus. While the primary latent period of the virus does not vary with challenge strain nor vaccine treatment of host, the time until the maximum viral shedding rate is increased with vaccination. CONCLUSIONS: Our approach provides the tools necessary for a formal analysis of the evolution of virulence in MDV, and potentially simpler and cheaper approaches to comparing the virulence of MDV strains. BioMed Central 2011-11-11 /pmc/articles/PMC3226581/ /pubmed/22078942 http://dx.doi.org/10.1186/1746-6148-7-70 Text en Copyright ©2011 Atkins et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Atkins, Katherine E Read, Andrew F Savill, Nicholas J Renz, Katrin G Walkden-Brown, Stephen W Woolhouse, Mark EJ Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title | Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title_full | Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title_fullStr | Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title_full_unstemmed | Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title_short | Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness |
title_sort | modelling marek's disease virus (mdv) infection: parameter estimates for mortality rate and infectiousness |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226581/ https://www.ncbi.nlm.nih.gov/pubmed/22078942 http://dx.doi.org/10.1186/1746-6148-7-70 |
work_keys_str_mv | AT atkinskatherinee modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness AT readandrewf modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness AT savillnicholasj modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness AT renzkatring modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness AT walkdenbrownstephenw modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness AT woolhousemarkej modellingmareksdiseasevirusmdvinfectionparameterestimatesformortalityrateandinfectiousness |